Neuronetics, Inc. (STIM) stock
Close on Nov 17, 2026Market cap $97.53MP/E –Yield –
Earnings
Neuronetics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Neuronetics's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 16, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 4, 2026before the open | $42.00M | +12.6% | -$0.02 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 11, 2026before the open | $41.60M | +9.2% | -$0.05 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 5, 2026before the open | $34.50M | +7.8% | – | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 17, 2026before the open | $41.80M | +85.8% | -$0.10 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 4, 2025before the open | $37.30M | +101.6% | -$0.13 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 5, 2025before the open | $38.10M | +130.9% | -$0.15 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 6, 2025before the open | $32.00M | +83.9% | -$0.21 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 4, 2025before the open | $22.50M | +10.8% | -$0.33 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 12, 2024before the open | $18.50M | +3.4% | -$0.44 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 12, 2024before the open | $16.50M | -6.3% | -$0.33 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 7, 2024before the open | $17.40M | +12.3% | -$0.27 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 5, 2024before the open | $20.30M | +11.5% | -$0.19 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 7, 2023before the open | $17.90M | +8.5% | -$0.33 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 8, 2023before the open | $17.60M | +8.0% | -$0.17 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 9, 2023before the open | $15.50M | +9.2% | -$0.38 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 7, 2023before the open | $18.20M | +21.3% | -$0.31 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 8, 2022before the open | $16.50M | +19.6% | -$0.28 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 2, 2022before the open | $16.30M | – | -$0.39 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 12, 2022before the open | $14.20M | – | -$0.41 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 8, 2022before the open | $15.00M | – | -$0.29 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 9, 2021before the open | $13.80M | – | -$0.31 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 3, 2021before the open | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 4, 2021before the open | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Mar 2, 2021before the open | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 2, 2020during market hours | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Neuronetics's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Total revenueGAAP | FY2026 | $160.00M – $164.00M | – | New | Nov 4, 2026 |
| Total revenue | FY2026 | $160.00M – $164.00M | $160.00M – $166.00M | Lowered | Aug 11, 2026 |
| Total Revenue | FY2026 | $160.00M – $166.00M | – | New | Mar 17, 2026 |
| Gross marginGAAP | FY2026 | 49% – 50% | – | New | Nov 4, 2026 |
| Gross margin | FY2026 | 48% – 50% | 47% – 49% | Raised | Aug 11, 2026 |
| Gross Margin | FY2026 | 47% – 49% | – | New | Mar 17, 2026 |
| Cash flow from operating and investing | FY2026 | -$12.00M – -$10.00M | – | New | Nov 4, 2026 |
| Cash flow from operations | FY2026 | -$17.00M – -$13.00M | – | Lowered | May 5, 2026 |
| Cash flow from operations and investing | FY2026 | -$14.50M – -$10.50M | – | Raised | Aug 11, 2026 |
| Operating Cash Flow | FY2026 | -$17.00M – -$13.00M | – | Lowered | Mar 17, 2026 |
| Operating expensesGAAP | FY2026 | $92.50M – $95.50M | – | New | Nov 4, 2026 |
| Operating expensesGAAP | FY2026 | $95.00M – $100.00M | – | New | Aug 11, 2026 |
| Operating expensesnon-GAAP | FY2026 | $91.00M – $96.00M | – | New | Aug 11, 2026 |
| Operating expenses | FY2026 | $100.00M – $105.00M | – | New | May 5, 2026 |
| Operating Expenses | FY2026 | $100.00M – $105.00M | – | New | Mar 17, 2026 |
| Operating expenses, excluding stock-based compensationnon-GAAP | FY2026 | $89.00M – $92.00M | – | New | Nov 4, 2026 |
Guidance vs results
The last range Neuronetics gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q1 FY2026 | Revenue | $33.00M – $35.00M | $34.50M | Within range |
| FY2025 | Revenue | $147.00M – $150.00M | $149.20MΣ4Q | Within range |
| Q4 FY2025 | Revenue | $40.00M – $43.00M | $41.80M | Within range |
| Q3 FY2025 | Revenue | $37.00M – $39.00M | $37.30M | Within range |
| Q2 FY2025 | Revenue | $36.00M – $38.00M | $38.10M | Above range |
| Q1 FY2025 | Revenue | $28.00M – $30.00M | $32.00M | Above range |
| Q4 FY2024 | Revenue | $19.00M – $20.00M | $22.50M | Above range |
| Q3 FY2024 | Revenue | $18.50M – $19.50M | $18.50M | Within range |
| Q2 FY2024 | Revenue | $18.00M – $19.00M | $16.50M | Below range |
| Q1 FY2024 | Revenue | $16.70M – $17.70M | $17.40M | Within range |
| Q4 FY2023 | Revenue | $19.00M – $21.00M | $20.30M | Within range |
| Q3 FY2023 | Revenue | $17.00M – $18.00M | $17.90M | Within range |
| Q2 FY2023 | Revenue | $17.00M – $18.00M | $17.60M | Within range |
| Q1 FY2023 | Revenue | $15.00M – $16.00M | $15.50M | Within range |
| Q4 FY2022 | Revenue | $16.00M – $17.00M | $18.20M | Above range |
| Q3 FY2022 | Revenue | $14.50M – $15.50M | $16.50M | Above range |
| Q2 FY2022 | Revenue | $15.00M – $16.00M | $16.30M | Above range |
| Q1 FY2022 | Revenue | $13.00M – $14.00M | $14.20M | Above range |
| Q4 FY2021 | Revenue | $14.50M – $15.00M | $15.00M | Within range |
Guidance history
Every forecast Neuronetics put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 4, 2026 | Cash flow from operating and investing | FY2026 | -$12.00M – -$10.00M | New |
| Nov 4, 2026 | Gross margin | FY2026 | 49% – 50% | New |
| Nov 4, 2026 | Operating expenses | FY2026 | $92.50M – $95.50M | New |
| Nov 4, 2026 | Operating expenses, excluding stock-based compensation | FY2026 | $89.00M – $92.00M | New |
| Nov 4, 2026 | Total revenue | FY2026 | $160.00M – $164.00M | New |
| Aug 11, 2026 | Gross margin | FY2026 | 48% – 50% | Raised |
| Aug 11, 2026 | Cash flow from operations and investing | FY2026 | -$14.50M – -$10.50M | Raised |
| Aug 11, 2026 | Operating expenses | FY2026 | $95.00M – $100.00M | New |
| Aug 11, 2026 | Operating expenses | FY2026 | $91.00M – $96.00M | New |
| Aug 11, 2026 | Total revenue | FY2026 | $160.00M – $164.00M | Lowered |
| May 5, 2026 | Gross margin | FY2026 | 47% – 49% | New |
| May 5, 2026 | Operating expenses | FY2026 | $100.00M – $105.00M | New |
| May 5, 2026 | Cash flow from operations | FY2026 | -$17.00M – -$13.00M | Lowered |
| May 5, 2026 | Total revenue | FY2026 | $160.00M – $166.00M | New |
| Mar 17, 2026 | Gross Margin | FY2026 | 47% – 49% | New |
| Mar 17, 2026 | Operating Expenses | FY2026 | $100.00M – $105.00M | New |
| Mar 17, 2026 | Operating Cash Flow | FY2026 | -$17.00M – -$13.00M | Lowered |
| Mar 17, 2026 | total worldwide revenue | Q1 FY2026 | $33.00M – $35.00M | New |
| Mar 17, 2026 | Total Revenue | FY2026 | $160.00M – $166.00M | New |
| Nov 4, 2025 | gross margin | FY2025 | 47% – 49% | New |
| Nov 4, 2025 | total operating expenses | FY2025 | $100.00M – $105.00M | New |
| Nov 4, 2025 | total cash, consisting of cash, cash equivalents, and restricted cash | FY2025 | $32.00M – $36.00M | Lowered |
| Nov 4, 2025 | total worldwide revenue | FY2025 | $147.00M – $150.00M | New |
| Nov 4, 2025 | total worldwide revenue | Q4 FY2025 | $40.00M – $43.00M | New |
| Aug 5, 2025 | gross margin | FY2025 | 48% – 50% | Lowered |
| Aug 5, 2025 | total operating expenses | FY2025 | $100.00M – $105.00M | Raised |
| Aug 5, 2025 | total cash, inclusive of cash, cash equivalents, and restricted cash | FY2025 | $25.00M – $28.00M | Lowered |
| Aug 5, 2025 | total worldwide revenue | Q3 FY2025 | $37.00M – $39.00M | New |
| Aug 5, 2025 | total worldwide revenue | FY2025 | $149.00M – $155.00M | Reaffirmed |
| May 6, 2025 | gross margin | FY2025 | 55% | Reaffirmed |
| May 6, 2025 | total operating expenses | FY2025 | $90.00M – $98.00M | Reaffirmed |
| May 6, 2025 | total worldwide revenue | Q2 FY2025 | $36.00M – $38.00M | New |
| May 6, 2025 | total worldwide revenue | FY2025 | $149.00M – $155.00M | Raised |
| Mar 4, 2025 | gross margin | FY2025 | 55% | Reaffirmed |
| Mar 4, 2025 | total operating expenses | FY2025 | $90.00M – $98.00M | Reaffirmed |
| Mar 4, 2025 | total worldwide revenue | Q1 FY2025 | $28.00M – $30.00M | New |
| Mar 4, 2025 | total worldwide revenue | FY2025 | $145.00M – $155.00M | Reaffirmed |
| Jan 13, 2025 | Gross margin | FY2025 | 55% | New |
| Jan 13, 2025 | Operating expenses | FY2025 | $90.00M – $98.00M | New |
| Jan 13, 2025 | pro forma year-over-year revenue growth | FY2025 | +12% – +19% | New |
| Jan 13, 2025 | Total Revenue | FY2025 | $145.00M – $155.00M | New |
| Nov 12, 2024 | total operating expenses | FY2024 | $81.00M – $82.00M | Raised |
| Nov 12, 2024 | total worldwide revenue | Q4 FY2024 | $19.00M – $20.00M | New |
| Nov 12, 2024 | total worldwide revenue | FY2024 | $71.00M – $72.00M | Lowered |
| Aug 12, 2024 | total operating expenses | FY2024 | $78.00M – $80.00M | Lowered |
| Aug 12, 2024 | total worldwide revenue | Q3 FY2024 | $18.50M – $19.50M | New |
| Aug 12, 2024 | total worldwide revenue | FY2024 | $78.00M – $80.00M | Reaffirmed |
| May 7, 2024 | total operating expenses | FY2024 | $80.00M – $84.00M | Reaffirmed |
| May 7, 2024 | total worldwide revenue | Q2 FY2024 | $18.00M – $19.00M | New |
| May 7, 2024 | total worldwide revenue | FY2024 | $78.00M – $80.00M | Reaffirmed |
| Mar 5, 2024 | total operating expenses | FY2024 | $80.00M – $84.00M | New |
| Mar 5, 2024 | total worldwide revenue | Q1 FY2024 | $16.70M – $17.70M | New |
| Mar 5, 2024 | total worldwide revenue | FY2024 | $78.00M – $80.00M | New |
| Nov 7, 2023 | total operating expenses | FY2023 | $82.00M – $84.00M | Lowered |
| Nov 7, 2023 | total revenue | Q4 FY2023 | $19.00M – $21.00M | New |
| Nov 7, 2023 | total revenue | FY2023 | $70.00M – $72.00M | Narrowed |
| Aug 8, 2023 | total operating expenses | FY2023 | $82.00M – $86.00M | Lowered |
| Aug 8, 2023 | total revenue | Q3 FY2023 | $17.00M – $18.00M | New |
| Aug 8, 2023 | total revenue | FY2023 | $69.00M – $73.00M | Raised |
| May 9, 2023 | total operating expenses | FY2023 | $84.00M – $88.00M | Reaffirmed |
| May 9, 2023 | total worldwide revenue | Q2 FY2023 | $17.00M – $18.00M | New |
| May 9, 2023 | total worldwide revenue | FY2023 | $68.00M – $73.00M | Raised |
| Mar 7, 2023 | total operating expenses | FY2023 | $84.00M – $88.00M | New |
| Mar 7, 2023 | total worldwide revenue | Q1 FY2023 | $15.00M – $16.00M | New |
| Mar 7, 2023 | total worldwide revenue | FY2023 | $66.00M – $72.00M | New |
| Nov 8, 2022 | total operating expenses | FY2022 | $86.00M – $88.00M | Reaffirmed |
| Nov 8, 2022 | total worldwide revenue | Q4 FY2022 | $16.00M – $17.00M | New |
| Nov 8, 2022 | total worldwide revenue | FY2022 | $63.00M – $64.00M | Raised |
| Aug 2, 2022 | total operating expenses | FY2022 | $86.00M – $88.00M | Lowered |
| Aug 2, 2022 | total worldwide revenue | Q3 FY2022 | $14.50M – $15.50M | New |
| Aug 2, 2022 | total worldwide revenue | FY2022 | $60.00M – $62.00M | Raised |
| May 12, 2022 | total operating expenses | FY2022 | $86.00M – $90.00M | Reaffirmed |
| May 12, 2022 | total worldwide revenue | Q2 FY2022 | $15.00M – $16.00M | New |
| May 12, 2022 | total worldwide revenue | FY2022 | $58.00M – $62.00M | Reaffirmed |
| Mar 8, 2022 | total operating expenses | FY2022 | $86.00M – $90.00M | New |
| Mar 8, 2022 | total worldwide revenue | Q1 FY2022 | $13.00M – $14.00M | New |
| Mar 8, 2022 | total worldwide revenue | FY2022 | $58.00M – $62.00M | New |
| Jan 10, 2022 | total revenue | Q4 FY2021 | $14.50M – $15.00M | Raised |
| Jan 10, 2022 | total revenue | FY2021 | $54.80M – $55.30M | Raised |
| Nov 9, 2021 | total operating expenses | FY2021 | $69.00M – $71.00M | New |
| Nov 9, 2021 | total worldwide revenue | Q4 FY2021 | $13.00M – $14.00M | New |
| Nov 9, 2021 | total worldwide revenue | FY2021 | $53.30M – $54.30M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Neuronetics filed with the SEC as exhibits to Form 8-K or 6-K
- News
- News
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?